Entrada Therapeutics

TRDA · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings about 1 month ago

Total Revenue

$20.6M

Previous year: $59.1M

Research and development expenses

$32.1M

General and administrative expenses

$10.3M

Interest and other income

Loading...

Entrada Therapeutics

Unlock previous datapoints

Upgrade

Entrada Therapeutics

Unlock previous datapoints

Upgrade

Entrada Therapeutics Revenue by Segment

Revenue by Segment

Collaboration Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$457M

P/E Ratio

14.73

Sector

N/A

Industry

N/A

52-Week High

$13.5

52-Week Low

$4.99

Research and development expenses

$32.1M

General and administrative expenses

$10.3M

Interest and other income

$4.44M

Total operating expenses

$42.3M

Net cash used in operating activities

-$38.5M

Products

Get in Touch

Resources

Entrada Therapeutics

Entrada Therapeutics

Entrada Therapeutics

Entrada Therapeutics Revenue by Segment

Revenue by Segment

Collaboration Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics